These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 6312019

  • 1. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse.
    Porreca F, Burks TF.
    J Pharmacol Exp Ther; 1983 Oct; 227(1):22-7. PubMed ID: 6312019
    [Abstract] [Full Text] [Related]

  • 2. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F, Mosberg HI, Hurst R, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [Abstract] [Full Text] [Related]

  • 3. Role of peripheral mu, delta and kappa opioid receptors in opioid-induced inhibition of gastrointestinal transit in rats.
    Tavani A, Petrillo P, La Regina A, Sbacchi M.
    J Pharmacol Exp Ther; 1990 Jul; 254(1):91-7. PubMed ID: 2164103
    [Abstract] [Full Text] [Related]

  • 4. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F, Heyman JS, Mosberg HI, Omnaas JR, Vaught JL.
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [Abstract] [Full Text] [Related]

  • 5. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ, Roerig SC, Fujimoto JM.
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [Abstract] [Full Text] [Related]

  • 6. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG, Fields HL, Lee NM.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [Abstract] [Full Text] [Related]

  • 7. Dissociation of opioid antinociception and central gastrointestinal propulsion in the mouse: studies with naloxonazine.
    Heyman JS, Williams CL, Burks TF, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1988 Apr; 245(1):238-43. PubMed ID: 2834537
    [Abstract] [Full Text] [Related]

  • 8. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE, Lemcke PK, Gehrig CA, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [Abstract] [Full Text] [Related]

  • 9. Supraspinal and spinal potency of selective opioid agonists in the mouse writhing test.
    Porreca F, Mosberg HI, Omnaas JR, Burks TF, Cowan A.
    J Pharmacol Exp Ther; 1987 Mar; 240(3):890-4. PubMed ID: 3031278
    [Abstract] [Full Text] [Related]

  • 10. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
    Jiang Q, Takemori AE, Sultana M, Portoghese PS, Bowen WD, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
    [Abstract] [Full Text] [Related]

  • 11. Involvement of adenosine in antinociception produced by spinal or supraspinal receptor-selective opioid agonists: dissociation from gastrointestinal effects in mice.
    DeLander GE, Mosberg HI, Porreca F.
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1097-104. PubMed ID: 1335055
    [Abstract] [Full Text] [Related]

  • 12. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE, Pelton JT, Hruby VJ, Burks TF.
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
    Qi JA, Bowen WD, Mosberg HI, Rothman RB, Porreca F.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
    [Abstract] [Full Text] [Related]

  • 15. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW, Holtzman SG.
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [Abstract] [Full Text] [Related]

  • 16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC, Lei S, Kitto K, Hylden JK, Wilcox GL.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [Abstract] [Full Text] [Related]

  • 17. Delta but not mu-opioid receptors in the spinal cord are involved in antinociception induced by beta-endorphin given intracerebroventricularly in mice.
    Suh HH, Tseng LF.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):981-6. PubMed ID: 2162954
    [Abstract] [Full Text] [Related]

  • 18. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
    Jiang Q, Sheldon RJ, Porreca F.
    J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.